Welcome!
Home Clearbridge Health (CBH)
Investing ideas
This healthcare stock could be a multibagger as share price plunges to all-time low
Phillip Securities Research forecasts that the company will clock another year of positive EBITDA in FY2020.
March 10, 2020
Broker's Calls
Clearbridge Health started at ‘buy’ with 28 cents target by Phillip on growth trajectory
SINGAPORE (Apr 1): Phillip Securities is initiating coverage of Clearbridge Health (CBH) with a “buy”.
April 01, 2019
IPO
Clearbridge Health associate Biolidics lodges prelim prospectus
SINGAPORE (Nov 26): Biolidics, a cancer diagnostic solutions developer and an associate company of Clearbridge Health, on Friday lodged a preliminary prospectus for a planned initial public offering (IPO) on the Singapore Exchange's Catalist board.
November 26, 2018
M&A
Clearbridge Health to acquire 65% stake in medical centre in Manila
SINGAPORE (Jan 4): Clearbridge Health’s wholly-owned subsidiary, Clearbridge Health (Philippines), has entered into a conditional share purchase agreement to acquire 65% of the common shares in the issued share capital of Marzan Health Care Inc for 69.6
January 04, 2018
IPO
How clear is Clearbridge Health post-listing outlook?
SINGAPORE (Dec 14): Clearbridge Health (CBH), the healthcare firm which focuses on the delivery of precision medicine, boosts a capable team to lead its expansion across Asia, says Maybank KimEng.
December 14, 2017